
IICT pact with bio-pharma firm for anti-COVID drug
The Hindu
CSIR-Indian Institute of Chemical Technology Hyderabad (IICT) and Anthem Biosciences Pvt. Ltd., a Bengaluru-based integrated biopharmaceutical company, signed an agreement for technology transfer and
CSIR-Indian Institute of Chemical Technology Hyderabad (IICT) and Anthem Biosciences Pvt. Ltd., a Bengaluru-based integrated biopharmaceutical company, signed an agreement for technology transfer and manufacture of the anti0COVID drug 2-DG or 2-Deoxy-D-Glucose on Tuesday. Studies have shown that the oral drug 2- DG has demonstrated quick recovery and reduction in oxygen dependence among moderately and severely affected patients. This drug in the form of powder formulation was earlier launched by Dr. Reddy’s Laboratories. Under the terms of the license agreement, Anthem Biosciences Pvt. Ltd. gets non-exclusive license for the process knowhow for synthesis of 2-DG . “The agreement is in-line with CSIR’s efforts to help people access various therapeutic options to combat COVID-19. CSIR labs have undertaken clinical trials of various repurposed drugs for the treatment of COVID-19,” said IICT director S. Chandrasekhar.More Related News

Tamil Nadu Assembly election 2026: TMC(M) gets five seats in NDA, to contest on BJP's 'Lotus' symbol
TMC(M) secures five NDA seats, to contest Assembly elections using BJP's 'Lotus' symbol in Tamil Nadu.

The Karnataka government will discuss with officials the possibility of creating a portal for unemployed youth to share their details and access job opportunities in micro, small and medium enterprises (MSMEs), Minister for Small Industries and Public Enterprises Sharanabasappa Darshanapur said in the Legislative Council on Tuesday.











